KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pfizer (PFE) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Pfizer (PFE) over the last 17 years, with Q2 2025 value amounting to $25.0 million.

  • Pfizer's Consolidated Net Income rose 4705.88% to $25.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 21363.64%. This contributed to the annual value of $11.0 million for FY2024, which is 17333.33% up from last year.
  • Per Pfizer's latest filing, its Consolidated Net Income stood at $25.0 million for Q2 2025, which was up 4705.88% from -$8.0 million recorded in Q3 2024.
  • In the past 5 years, Pfizer's Consolidated Net Income registered a high of $34.0 million during Q3 2022, and its lowest value of -$236.0 million during Q3 2021.
  • For the 5-year period, Pfizer's Consolidated Net Income averaged around -$16.4 million, with its median value being -$3.5 million (2023).
  • Per our database at Business Quant, Pfizer's Consolidated Net Income crashed by 100000.0% in 2022 and then skyrocketed by 95000.0% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Consolidated Net Income stood at -$13.0 million in 2021, then crashed by 61.54% to -$21.0 million in 2022, then decreased by 23.81% to -$26.0 million in 2023, then skyrocketed by 69.23% to -$8.0 million in 2024, then skyrocketed by 412.5% to $25.0 million in 2025.
  • Its Consolidated Net Income was $25.0 million in Q2 2025, compared to -$8.0 million in Q3 2024 and $17.0 million in Q2 2024.